The Fort Worth Press - US abortion ruling threatens access to arthritis drug

USD -
AED 3.673039
AFN 69.000382
ALL 89.101678
AMD 387.749826
ANG 1.804889
AOA 928.475981
ARS 962.7414
AUD 1.46872
AWG 1.8
AZN 1.710825
BAM 1.753412
BBD 2.022028
BDT 119.677429
BGN 1.76065
BHD 0.376814
BIF 2894
BMD 1
BND 1.293151
BOB 6.920294
BRL 5.425499
BSD 1.001511
BTN 83.756981
BWP 13.175564
BYN 3.277435
BYR 19600
BZD 2.018612
CAD 1.356395
CDF 2871.000085
CHF 0.84791
CLF 0.033735
CLP 930.859741
CNY 7.067977
CNH 7.07284
COP 4165.25
CRC 518.757564
CUC 1
CUP 26.5
CVE 99.250254
CZK 22.491396
DJF 177.72004
DKK 6.684975
DOP 60.203552
DZD 132.341911
EGP 48.534057
ERN 15
ETB 117.497487
EUR 0.896196
FJD 2.2003
FKP 0.761559
GBP 0.753255
GEL 2.729512
GGP 0.761559
GHS 15.701624
GIP 0.761559
GMD 68.504127
GNF 8652.498216
GTQ 7.741513
GYD 209.457218
HKD 7.793945
HNL 24.949828
HRK 6.799011
HTG 131.977784
HUF 353.230215
IDR 15202
ILS 3.750095
IMP 0.761559
INR 83.61045
IQD 1310
IRR 42092.504652
ISK 136.490277
JEP 0.761559
JMD 157.339131
JOD 0.708698
JPY 142.851991
KES 128.999539
KGS 84.275012
KHR 4069.999863
KMF 441.350282
KPW 899.999433
KRW 1329.045033
KWD 0.30494
KYD 0.834476
KZT 479.593026
LAK 22085.000237
LBP 89268.117889
LKR 304.846178
LRD 194.249486
LSL 17.502706
LTL 2.95274
LVL 0.60489
LYD 4.745018
MAD 9.695018
MDL 17.473892
MGA 4555.000175
MKD 55.200186
MMK 3247.960992
MNT 3397.999955
MOP 8.038636
MRU 39.715032
MUR 45.869795
MVR 15.36002
MWK 1736.00021
MXN 19.317199
MYR 4.218972
MZN 63.849846
NAD 17.499915
NGN 1640.319638
NIO 36.769417
NOK 10.503135
NPR 134.027245
NZD 1.604145
OMR 0.384961
PAB 1.001511
PEN 3.745005
PGK 3.914203
PHP 55.562997
PKR 278.098209
PLN 3.83075
PYG 7817.718069
QAR 3.64025
RON 4.457506
RSD 104.909468
RUB 92.170071
RWF 1342
SAR 3.752548
SBD 8.306937
SCR 13.623023
SDG 601.497767
SEK 10.16481
SGD 1.292595
SHP 0.761559
SLE 22.847303
SLL 20969.494858
SOS 570.999811
SRD 29.852962
STD 20697.981008
SVC 8.762579
SYP 2512.529936
SZL 17.503112
THB 33.1435
TJS 10.644256
TMT 3.5
TND 3.024035
TOP 2.3498
TRY 34.084935
TTD 6.806508
TWD 31.924966
TZS 2724.999896
UAH 41.500415
UGX 3718.795247
UYU 41.141269
UZS 12735.000116
VEF 3622552.534434
VES 36.755455
VND 24580
VUV 118.722009
WST 2.797463
XAF 588.099177
XAG 0.032507
XAU 0.000387
XCD 2.70255
XDR 0.742235
XOF 587.50055
XPF 107.297095
YER 250.324957
ZAR 17.510415
ZMK 9001.198401
ZMW 26.062595
ZWL 321.999592
  • BCC

    7.6300

    144.69

    +5.27%

  • CMSD

    0.0300

    25.01

    +0.12%

  • BCE

    -0.4200

    35.19

    -1.19%

  • GSK

    -0.8100

    41.62

    -1.95%

  • RIO

    2.2700

    65.18

    +3.48%

  • BTI

    -0.3100

    37.57

    -0.83%

  • RBGPF

    3.5000

    60.5

    +5.79%

  • SCS

    -0.8000

    13.31

    -6.01%

  • JRI

    -0.0400

    13.4

    -0.3%

  • NGG

    -1.2200

    68.83

    -1.77%

  • CMSC

    0.0650

    25.12

    +0.26%

  • BP

    0.3300

    32.76

    +1.01%

  • RYCEF

    0.4000

    6.95

    +5.76%

  • VOD

    -0.1700

    10.06

    -1.69%

  • RELX

    0.7600

    48.13

    +1.58%

  • AZN

    0.3200

    78.9

    +0.41%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: © POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

T.Harrison--TFWP